GuoA., MujaisS.Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts.Kidney Int Suppl2003; 88: S3–12.
2.
Rodriguez-CarmonaA., Perez FontanM.Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.Perit Dial Int2002; 22: 705–13.
3.
HuffnagelG., MichelC., QueffeulouG., SkhiriH., DamieriH., MignonF.The influence of automated peritoneal dialysis on the decrease in residual renal function.Nephrol Dial Transplant1999; 14: 1224–8.
4.
RippeB., LevinL.Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.Kidney Int2000; 57: 2546–56.
5.
PlumJ., GentileS., VergerC., BrunkhorstR., BahnerU., FallerB.Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.Am J Kidney Dis2002; 39: 862–71.
6.
WolfsonM., PirainoB., HamburgerJ., MortonA.R., for the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.Am J Kidney Dis2002; 40: 1055–65.
7.
JelokaT.K., ErsoyF.F., YavuzM., SahuK.M., ÇamsariT., UtasC.What is the optimal dwell time for maximizing ultra-filtration with icodextrin exchange in automated peritoneal dialysis patients?Perit Dial Int2006; 26: 336–40.
8.
MoberlyJ.B., MujaisS., GehrT., HamburgerR., SpragueS., KucharskiA.Pharmacokinetics of icodextrin in peritoneal dialysis patients.Kidney Int Suppl2002; 81: S23–33.
9.
FinkelsteinF., HealyH., Abu AlfaA., AhmadS., BrownF., GehrT.Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.J Am Soc Nephrol2005; 16: 546–56.
10.
Cueto-ManzanoA.M., Rojas-CamposE., Martinez-RamirezH.R., Valera-GonzálezI., MedinaM., MonteónF.Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?Perit Dial Int2006; 26: 341–8.
11.
LevineB., KalmanJ., MayerL., FillitH.M., PackerM.Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.N Engl J Med1990; 323: 236–41.
12.
SelbyN.M., FonsecaS., HulmeL., FluckR.J., TaalM.W., McIntyreC.W.Hypertonic glucose based peritoneal dialysis is associated with higher blood pressure and adverse hemodynamics as compared with icodextrin.Nephrol Dial Transplant2005; 20: 1848–53.
13.
SelbyN.M., FonsecaS., HulmeL., FluckR.J., TaalM.W., McIntyreC.W.Automated peritoneal dialysis has significant effects on systemic hemodynamics.Perit Dial Int2006; 26: 328–35.
14.
De FijterC.W., OeL., NautaJ.J., van der MeulenJ., VerbrughH.A., DonkerA.J.Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis.Ann Intern Med1994; 120: 264–71.
15.
BroS., BjornerJ.B., Tofte-JensenP., KlemS., AlmtoftB., DanielsenH.A prospective randomized multicenter study comparing CAPD and APD treatment.Perit Dial Int1999; 19: 526–33.
